Dong-A ST logo

Dong-A ST

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide.

Investor Profile

Dong-A ST has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series D (33%)

Country Focus

  • United States (67%)
  • South Korea (33%)

Industry Focus

  • Health Care
  • Biotechnology
  • Manufacturing
  • Medical Device
  • Genetics
  • Pharmaceutical
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dong-A ST frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Korea Technology Finance Corporation
Asia, Pusan-jikhalsi, South Korea, Busan
Co-Investments: 1
E&Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Securities
North America, New York, United States, Nyack
Co-Investments: 1
Kingo Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 1
Shinhan Venture Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
InterVest Co.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Timepolio Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SJ Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Dong-A ST?

GenEdit

South San Francisco, California, United States

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series AJan 23, 2024
Amount Raised: $24,000,000
MEZOO

Wonju, Kangwon-do, South Korea

MEZOO is a medical device manufacturing company.

Health CareManufacturingMedical Device
Series BNov 7, 2023
Amount Raised: $13,793,368
Antiva Biosciences

Del Mar, California, United States

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

BiotechnologyHealth CareMedical
Series DNov 2, 2021
Amount Raised: $31,000,000